Learn how to distinguish true ADHD from anxiety, trauma, sleep issues, or substance use by tracing symptoms back to childhood across settings and impairment.

NHIS data show the share of US children aged 5 to 17 years ever diagnosed with ADHD climbed from 9.9% in 2019 to 13.8% in 2025.

Lower maternal PlGF in the third trimester was tied to child ADHD in a University of Iowa cohort, independent of preeclampsia and FGR.

Find out the 4 FDA decisions to watch in November 2026 for pediatric care.

Cenobamate sNDAs target PGTC seizures in patients ≥12 years and pediatric focal seizures; phase 3 PGTC data showed a 71.9% median reduction.

FDA approved Lupin's generic of Firdapse for LEMS in patients 6 years and older, but a patent settlement delays US marketing until at least 2035.

A recap of the top pediatric clinical trial results and pipeline data readouts during October 2026.

A recap of the top FDA approvals, regulatory decisions, and pipeline updates affecting pediatric care during October 2026.